KAY LOVE: Open Payments
NPI 1154666402 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 26 payments from 16 companies in 2025. Trend: 2023 $303 · 2024 $239 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $92 |
| Novo Nordisk Inc | 4 | $83 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| PFIZER INC. | 2 | $40 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Zimmer Biomet Holdings, Inc. | 1 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $27 |
| ALK-Abello, Inc | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
Products named: MOUNJARO, Ozempic, TRELEGY ELLIPTA, NURTEC ODT, INJECTAFER, Tlando, Persona, Wegovy.
Industry payments across NC — which companies pay providers there.
